Company intelligence / Profile preview
Alitair Pharmaceuticals
Morristown, New Jersey, United Statesalitairpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Alitair Pharmaceuticals focuses on developing proprietary prescription therapies addressing unmet needs in respiratory medicine. Its lead program, ALT‑07 (doxofylline), an oral bronchodilator with anti-inflammatory properties, has received orphan drug designation from the FDA for bronchiectasis. The company also develops non-narcotic cough medicines and holds patents related to overdose reduction technologies.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Small molecules (e.g., doxofylline)Ion exchange resin formulationsProprietary abuse deterrent/overdose reduction technology
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Actively seeking strategic partners for development/commercialization but no specific major partnerships disclosed as of now.
Beyond the preview
Go deeper on Alitair Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alitair Pharmaceuticals.